Defining the Molecular Risk in Israeli Patients With Secondary Compared to Primary Myelofibrosis
Clinical trial NCT03402399 · UNKNOWN
Trial details
- NCT number
- NCT03402399
- Sponsor
- Assaf-Harofeh Medical Center
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-10
- Primary completion
- 2019-12-09
- Enrollment
- 222
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.